HIGH-LEVELS OF NERVOUS SYSTEM-SPECIFIC PROTEINS IN CEREBROSPINAL-FLUID IN PATIENTS WITH EARLY STAGE CREUTZFELDT-JAKOB DISEASE

被引:70
作者
JIMI, T
WAKAYAMA, Y
SHIBUYA, S
NAKATA, H
TOMARU, T
TAKAHASHI, Y
KOSAKA, K
ASANO, T
KATO, K
机构
[1] SHOWA UNIV,FUJIGAOKA HOSP,DEPT ANESTHESIOL,MIDORI KU,YOKOHAMA 227,JAPAN
[2] ST MARIANNA MED UNIV,YOKOHAMA CITY SEIBU HOSP,DEPT NEUROL,ASAHI KU,YOKOHAMA 241,JAPAN
[3] YOKOHAMA CITY UNIV,SCH MED,DEPT PSYCHIAT,KANAZAWA KU,YOKOHAMA 236,JAPAN
[4] AICHI PREFECTURAL COLONY,INST DEV RES,DEPT BIOCHEM,KASUGAI,AICHI 48003,JAPAN
关键词
CREUTZFELDT-JAKOB DISEASE; CEREBROSPINAL FLUID; NEURON-SPECIFIC ENOLASE; S-100B PROTEIN; CREATINE KINASE ISOENZYMES; GUANINE NUCLEOTIDE-BINDING PROTEIN;
D O I
10.1016/0009-8981(92)90103-W
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Concentrations of several proteins that are characteristic of the nervous system were time-sequentially analyzed by radio- and enzyme-immunoassay in the cerebrospinal fluid (CSF) of patients with Creutzfeldt-Jakob disease (CJD). We found abnormally high levels of several proteins, such as neuron-specific enolase (NSE), S-100b protein, brain-type isozyme of creatine kinase (CK-BB) and alpha subunit of GTP binding protein G0 (Goalpha) in the early stage of the disease. Generally, these protein levels were far higher in CJD patients than in normal controls and other neurological patients in the early stage before the typical clinical manifestations were evident. These levels increased to maxima when the disease activity was most prominent and returned to normal or mildly elevated levels in the terminal stage. The results imply that these protein levels can serve as biochemical markers for the presence of an active destructive process in CJD brain and provide us with a useful indicator for early diagnosis of CJD.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 21 条
  • [1] HIGHLY SENSITIVE IMMUNOASSAY FOR THE ALPHA-SUBUNIT OF THE GTP-BINDING PROTEIN GO AND ITS REGIONAL DISTRIBUTION IN BOVINE BRAIN
    ASANO, T
    SEMBA, R
    OGASAWARA, N
    KATO, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 48 (05) : 1617 - 1623
  • [2] INCREASED GFAP LEVELS IN CSF AS A MARKER OF ORGANICITY IN PATIENTS WITH ALZHEIMERS-DISEASE AND OTHER TYPES OF IRREVERSIBLE CHRONIC ORGANIC BRAIN-SYNDROME
    CROLS, R
    SAERENS, J
    NOPPE, M
    LOWENTHAL, A
    [J]. JOURNAL OF NEUROLOGY, 1986, 233 (03) : 157 - 160
  • [3] CREUTZFELDT-JAKOB DISEASE (SPONGIFORM ENCEPHALOPATHY) - TRANSMISSION TO CHIMPANZEE
    GIBBS, CJ
    GAJDUSEK, DC
    ASHER, DM
    ALPERS, MP
    BECK, E
    DANIEL, PM
    MATTHEWS, WB
    [J]. SCIENCE, 1968, 161 (3839) : 388 - &
  • [4] G-PROTEINS AND DUAL CONTROL OF ADENYLATE-CYCLASE
    GILMAN, AG
    [J]. CELL, 1984, 36 (03) : 577 - 579
  • [5] JUBELT B, 1984, MERRITTS TXB NEUROLO, P79
  • [6] KATO K, 1983, METHOD ENZYMOL, V92, P345
  • [7] KATO K, 1976, J IMMUNOL, V116, P1554
  • [8] HIGHLY SENSITIVE ENZYME-IMMUNOASSAY FOR HUMAN CREATINE-KINASE BB ISOZYME
    KATO, K
    SHIMIZU, A
    ISHIGURO, Y
    MOKUNO, K
    ARIYOSHI, Y
    NAKAJIMA, T
    [J]. CLINICA CHIMICA ACTA, 1985, 150 (01) : 31 - 40
  • [9] REGIONAL DISTRIBUTION OF S-100A0 (ALPHA-ALPHA), S-100A (ALPHA-BETA) AND S-100B (BETA-BETA) IN THE BOVINE CENTRAL NERVOUS-TISSUE DETERMINED WITH A SENSITIVE ENZYME-IMMUNOASSAY SYSTEM
    KIMURA, S
    KATO, K
    SEMBA, R
    ISOBE, T
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (04) : 513 - 518
  • [10] FAMILIAL MYOCLONIC DEMENTIA MASQUERADING AS CREUTZFELDT-JAKOB DISEASE
    LITTLE, BW
    BROWN, PW
    RODGERSJOHNSON, P
    PERL, DP
    GAJDUSEK, DC
    [J]. ANNALS OF NEUROLOGY, 1986, 20 (02) : 231 - 239